Clinical Trial Update: Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update shows completion of an irbesartan study in hypertensive patients with metabolic syndrome. The update does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Metabolic Syndrome

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Metabolic Syndrome, Hypertension | Phase 4 | Status: COMPLETED